TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL PAINKILLER MARKET, BY DRUG CLASS
6.1. Overview
6.2. Opioids
6.3. Tramadol
6.4. Oxycodone
6.5. Hydrocodone
6.6. Other Opioids
6.7. NSAIDs
6.8. Local Anesthetics
6.9. Acetaminophen
7. GLOBAL PAINKILLER MARKET, BY PRODUCT
7.1. Overview
7.2. OTC Products
7.3. Prescription Drugs
8. GLOBAL PAINKILLER MARKET, BY INDICATION
8.1. Overview
8.2. Surgical Pain
8.3. Cancer Pain
8.4. Neuropathic Pain
8.5. Musculoskeletal and Joint Pain
8.6. Others
9. GLOBAL PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION
9.1. Overview
9.2. Injectable
9.3. Oral
9.4. Rectal
9.5. Topical
9.6. Transdermal
9.7. Others
10. GLOBAL PAINKILLER MARKET, BY DISTRIBUTION CHANNEL
10.1. Overview
10.2. Hospital Pharmacies
10.3. Specialty Clinics
10.4. Long-Term Care Centers
10.5. Retail Pharmacies
10.6. Drug Stores
10.7. Online Pharmacies
11. GLOBAL PAINKILLER MARKET, BY REGION
11.1. Overview
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. Germany
11.2.2. France
11.2.3. UK
11.2.4. Italy
11.2.5. Spain
11.2.6. Rest of Europe
11.3. Asia-Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. South Korea
11.3.5. Australia
11.3.6. Rest of Asia-Pacific
11.4. Rest of the World
11.4.1. Middle East
11.4.2. Africa
11.4.3. Latin America
12. COMPETITIVE LANDSCAPE
12.1. Overview
12.2. Competitive Analysis
12.3. Market Share Analysis
12.4. Major Growth Strategy in the Global Painkiller Market,
12.5. Competitive Benchmarking
12.6. Leading Players in Terms of Number of Developments in the Global Painkiller Market,
12.7. Key developments and Growth Strategies
12.7.1. New Product Launch/Service Deployment
12.7.2. Merger & Acquisitions
12.7.3. Joint Ventures
12.8. Major Players Financial Matrix
12.8.1. Sales & Operating Income, 2022
12.8.2. Major Players R&D Expenditure. 2022
13. COMPANY PROFILES
13.1. Pfizer Inc.
13.1.1. Company Overview
13.1.2. Financial Overview
13.1.3. Products Offered
13.1.4. Key Developments
13.1.5. SWOT Analysis
13.1.6. Key Strategies
13.2. Novartis AG
13.2.1. Company Overview
13.2.2. Financial Overview
13.2.3. Products Offered
13.2.4. Key Developments
13.2.5. SWOT Analysis
13.2.6. Key Strategies
13.3. Johnson & Johnson
13.3.1. Company Overview
13.3.2. Financial Overview
13.3.3. Products Offered
13.3.4. Key Developments
13.3.5. SWOT Analysis
13.3.6. Key Strategies
13.4. GlaxoSmithKline plc
13.4.1. Company Overview
13.4.2. Financial Overview
13.4.3. Products Offered
13.4.4. Key Developments
13.4.5. SWOT Analysis
13.4.6. Key Strategies
13.5. Bayer AG
13.5.1. Company Overview
13.5.2. Financial Overview
13.5.3. Products Offered
13.5.4. Key Developments
13.5.5. SWOT Analysis
13.5.6. Key Strategies
13.6. Eli Lilly and Company
13.6.1. Company Overview
13.6.2. Financial Overview
13.6.3. Products Offered
13.6.4. Key Developments
13.6.5. SWOT Analysis
13.6.6. Key Strategies
13.7. Sanofi S.A.
13.7.1. Company Overview
13.7.2. Financial Overview
13.7.3. Products Offered
13.7.4. Key Developments
13.7.5. SWOT Analysis
13.7.6. Key Strategies
13.8. MERCK & CO., INC.
13.8.1. Company Overview
13.8.2. Financial Overview
13.8.3. Products Offered
13.8.4. Key Developments
13.8.5. SWOT Analysis
13.8.6. Key Strategies
13.9. AstraZeneca plc
13.9.1. Company Overview
13.9.2. Financial Overview
13.9.3. Products Offered
13.9.4. Key Developments
13.9.5. SWOT Analysis
13.9.6. Key Strategies
13.10. Teva Pharmaceutical Industries Ltd.
13.10.1. Company Overview
13.10.2. Financial Overview
13.10.3. Products Offered
13.10.4. Key Developments
13.10.5. SWOT Analysis
13.10.6. Key Strategies
14. APPENDIX
14.1. References
14.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL PAINKILLER MARKET, SYNOPSIS, 2018-2032
TABLE 2 GLOBAL PAINKILLER MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 7 GLOBAL PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 11 NORTH AMERICA: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 12 NORTH AMERICA: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 13 US: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 14 US: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 15 US: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 16 US: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 17 US: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 18 CANADA: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 19 CANADA: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 20 CANADA: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 21 CANADA: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 22 CANADA: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 23 EUROPE: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 24 EUROPE: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 25 EUROPE: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 26 EUROPE: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 27 EUROPE: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 28 GERMANY: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 29 GERMANY: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 30 GERMANY: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 31 GERMANY: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 32 GERMANY: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 33 FRANCE: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 34 FRANCE: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 35 FRANCE: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 36 FRANCE: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 37 FRANCE: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 38 ITALY: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 39 ITALY: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 40 ITALY: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 41 ITALY: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 42 ITALY: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 43 SPAIN: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 44 SPAIN: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 45 SPAIN: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 46 SPAIN: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 47 SPAIN: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 48 UK: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 49 UK: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 50 UK: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 51 UK: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 52 UK: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 53 REST OF EUROPE: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 54 REST OF EUROPE: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 55 REST OF EUROPE: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 56 REST OF EUROPE: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 57 REST OF EUROPE: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 58 ASIA-PACIFIC: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 59 ASIA-PACIFIC: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 60 ASIA-PACIFIC: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 61 ASIA-PACIFIC: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 62 ASIA-PACIFIC: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 63 JAPAN: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 64 JAPAN: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 65 JAPAN: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 66 JAPAN: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 67 JAPAN: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 68 CHINA: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 69 CHINA: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 70 CHINA: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 71 CHINA: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 72 CHINA: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 73 INDIA: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 74 INDIA: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 75 INDIA: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 76 INDIA: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 77 INDIA: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 78 AUSTRALIA: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 79 AUSTRALIA: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 80 AUSTRALIA: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 81 AUSTRALIA: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 82 AUSTRALIA: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 83 SOUTH KOREA: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 84 SOUTH KOREA: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 85 SOUTH KOREA: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 86 SOUTH KOREA: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 87 SOUTH KOREA: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 88 REST OF ASIA-PACIFIC: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 89 REST OF ASIA-PACIFIC: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 90 REST OF ASIA-PACIFIC: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 91 REST OF ASIA-PACIFIC: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 92 REST OF ASIA-PACIFIC: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 93 REST OF THE WORLD: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 94 REST OF THE WORLD: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 95 REST OF THE WORLD: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 96 REST OF THE WORLD: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 97 REST OF THE WORLD: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 98 MIDDLE EAST: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 99 MIDDLE EAST: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 100 MIDDLE EAST: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 101 MIDDLE EAST: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 102 MIDDLE EAST: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 103 AFRICA: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 104 AFRICA: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 105 AFRICA: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 106 AFRICA: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 107 AFRICA: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
TABLE 108 LATIN AMERICA: PAINKILLER MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 109 LATIN AMERICA: PAINKILLER MARKET, BY PRODUCT, 2018-2032 (USD BILLION)
TABLE 110 LATIN AMERICA: PAINKILLER MARKET, BY INDICATION, 2018-2032 (USD BILLION)
TABLE 111 LATIN AMERICA: PAINKILLER MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD BILLION)
TABLE 112 LATIN AMERICA: PAINKILLER MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PAINKILLER MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PAINKILLER MARKET
FIGURE 4 GLOBAL PAINKILLER MARKET, SHARE (%), BY DRUG CLASS, 2022
FIGURE 5 GLOBAL PAINKILLER MARKET, SHARE (%), BY PRODUCT, 2022
FIGURE 6 GLOBAL PAINKILLER MARKET, SHARE (%), BY INDICATION, 2022
FIGURE 7 GLOBAL PAINKILLER MARKET, SHARE (%), BY ROUTE OF ADMINISTRATION, 2022
FIGURE 8 GLOBAL PAINKILLER MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 9 GLOBAL PAINKILLER MARKET, SHARE (%), BY END-USERS, 2022
FIGURE 10 GLOBAL PAINKILLER MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
FIGURE 11 GLOBAL PAINKILLER MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 NORTH AMERICA: PAINKILLER MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 EUROPE: PAINKILLER MARKET, SHARE (%), BY REGION, 2022
FIGURE 14 ASIA-PACIFIC: PAINKILLER MARKET, SHARE (%), BY REGION, 2022
FIGURE 15 REST OF THE WORLD: PAINKILLER MARKET, SHARE (%), BY REGION, 2022
FIGURE 16 GLOBAL PAINKILLER MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 17 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 PFIZER INC.: SWOT ANALYSIS
FIGURE 19 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 NOVARTIS AG: SWOT ANALYSIS
FIGURE 21 JOHNSON & JOHNSON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 JOHNSON & JOHNSON: SWOT ANALYSIS
FIGURE 23 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 GLAXOSMITHKLINE PLC: SWOT ANALYSIS
FIGURE 25 BAYER AG.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 BAYER AG.: SWOT ANALYSIS
FIGURE 27 ELI LILLY AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 ELI LILLY AND COMPANY: SWOT ANALYSIS
FIGURE 29 SANOFI S.A.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 SANOFI S.A.: SWOT ANALYSIS
FIGURE 31 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 MERCK & CO., INC.: SWOT ANALYSIS
FIGURE 33 ASTRAZENECA PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ASTRAZENECA PLC: SWOT ANALYSIS
FIGURE 35 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
